SCHEMBL5899417

SCHEMBL5899417

CC(C)(NS(=O)(=O)c1ccc(-c2ccccc2)cc1)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 3/20 0.50
MMP1 P03956 3/20 0.49
MMP12 P39900 2/20 0.49
GAA P10253 2/20 0.49
MMP2 P08253 7/20 0.48
MMP9 P14780 5/20 0.48
MMP3 P08254 3/20 0.48
MMP13 P45452 3/20 0.48
MMP7 P09237 2/20 0.48
MMP8 P22894 1/20 0.46
MMP14 P50281 1/20 0.46
ADAM17 P78536 1/20 0.46
MEP1B Q16820 1/20 0.46
BCL2L1 Q07817 1/20 0.45
MCL1 Q07820 1/20 0.45
POLB P06746 1/20 0.44
USP30 Q70CQ3 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899488 0.91 KAT6A (0.49) MMP1GAAMMP2MMP9MMP13
SCHEMBL5899419 0.88 ALDH1A1 (0.49) MMP1GAAMMP2MMP9MMP13
SCHEMBL5899418 0.87 PFKFB3 (0.54) MEN1MAPTKMT2AKAT6A
SCHEMBL5899422 0.87 FLT1 (0.57) MMP1MMP12GAAMMP2MMP9
SCHEMBL5899495 0.87 ALDH1A1 (0.50) MEN1MAPTRECQLKMT2AUQCRB
SCHEMBL5899463 0.87 ITGA1 (0.49) MMP1MMP2MMP9MMP3MMP13
SCHEMBL14675960 0.86 ADAMTS4 (0.54) ADAMTS4MMP1MMP12GAAMMP2
SCHEMBL5899456 0.84 MMP2 (0.59) ADAMTS4MMP1MMP2MMP9MMP3
SCHEMBL5899452 0.82 KAT6A (0.48) POLBUSP30MEN1MAPTHTT
SCHEMBL5899486 0.81 KAT6A (0.57) GAAKAT6A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ADAMTS4 397/4885MMP1 369/4885MMP12 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.